BACKGROUND/OBJECTIVES: Folic acid deficiency during pregnancy can lead to neural tube defects (NTD) in the fetus. Folate status was determined in a representative sample of Belgian pregnant women and determinants of folate status were assessed. SUBJECTS/METHODS: The women were selected using a multi-stage proportionate-to-size sampling design. Blood samples were collected and a questionnaire was completed face-to-face with a study nurse. Erythrocyte (red blood cell (RBC)) folate concentration was measured by chemoluminescence. RESULTS: In total, 1311 pregnant women participated and women with a lower socio-economic status were well represented. Median RBC folate concentration was 436 ng/ml (95% confidence interval ¼ 425-452 ng/ml) among first trimester and 496 ng/ml (95% confidence interval ¼ 474-515 ng/ml) among third trimester women. Few women had a RBC folate concentration below 140 ng/ml, indicating depletion of folate stores. In the first trimester, 39% of women had a RBC concentration below 400 ng/ml, whereas 15% of the first trimester women had a RBC concentration below 300 ng/ml. Among women in the first trimester, 69.1% reported taking folic acid-containing supplements of which 41.2% started taking them before pregnancy. For third trimester women, these percentages were 76.2% and 21.9%, respectively. In both trimesters, folate status increased significantly with education level and was significantly higher among women who planned the pregnancy and who did not smoke. CONCLUSIONS: It was found that 39% of the first trimester pregnant women had a folate status that might not be optimal to prevent NTD. Some groups of women need to be targeted as they are at higher risk of inadequate folate status.
INTRODUCTION
Folic acid is one of the B complex vitamins and is recognised as an important component of the periconceptional care of women of child-bearing age. Deficiency of folic acid can lead to neural tube defects (NTD) in the fetus and megaloblastic anaemia in the mother. Adequate folate intake before and during the first trimester of pregnancy is important for the closure of the neural tube in the fetus, which takes place between the second and the third week of pregnancy. 1 Risk of NTD is inversely associated with folate intake 2, 3 and erythrocyte folate concentration. 4 The recommended folate intake during pregnancy is twice as high as the recommended intake for the general population. 5 However, during pregnancy, it is difficult to fulfill the needs for folate only by food intake, and folic acid supplements are required starting before conception. Several clinical trials have shown that periconceptional supplementation with folic acid reduces the risk of NTD. [6] [7] [8] Taking supplements (400 mg/day) before conception and during the first trimester of pregnancy may decrease the risk of spina bifida with 72%. 9 In countries like the United States and Canada, the policy of mandatory fortification of flour with folic acid has proved effective in reducing the number of NTD. 10 In a prospective observational study in Norway, where food is not fortified with folic acid, lack of supplementation with folic acid from 4 weeks before to 8 weeks after conception was associated with an increased risk of severe language delay in the child at 3 years of age. 11 Several sequential stages in the development of folate deficiency have been previously described. 12 Stage 1 or early negative folate balance occurs when the individual is losing more folate than is being absorbed. This stage can be assessed by measuring serum folate levels, which drop before tissue depletion. The second stage of negative folate balance is tissue depletion, which is diagnosed by a red blood cell (RBC) folate level below 140 ng/ml. Stage 3 of negative folate balance is characterised by severe depletion of the vitamin. Intracellular folate becomes inadequate for normal folate-dependent metabolism, biochemical function is impaired and mean cell volume is increased. 12 The RBC folate level is a good biomarker for nutritional status of folate because of its correlation with liver folate, a significant tissue store. 13 Erythrocytes incorporate folate as they are formed in the bone marrow, and levels remain constant throughout the 120-day life span of the cell.
Thus, RBC folate concentrations change slowly with changes in intake. Serum folate concentrations are commonly accepted to reflect recent dietary folate intake and fluctuate with recent changes in folate intake or temporary changes in folate metabolism, even when body stores remain stable. Although RBC folate is considered to be a better indicator of body stores, and hence nutritional status, there is considerable uncertainty about the reliability of the analytical methods for determining RBC folate levels.
status that would not conventionally be classified as deficient. Maternal RBC folate X906 nmol/l (or 400 ng/ml) is generally considered optimal for the prevention of folate-responsive NTD. 4 This cutoff value is based on a case-control study in Ireland that showed a more than eightfold difference in risk between pregnant women with RBC folate levels less than 340 nmol/l (150 ng/ml), and a twofold difference in risk between pregnant women with RBC folate levels between 680 and 905 nmol/l (300-399 ng/ml), compared to those with levels of 906 nmol/l (400 ng/ml) or higher. 4 In Belgium, there is no official policy with regard to periconceptional folic acid supplementation. However, the Superior Health Council recommends all women planning a pregnancy to take 0.4 mg folic acid daily, starting before conception and during the first 3 months of pregnancy. 5 There is no official folic acid food fortification policy in Belgium. However, some fortified products such as breakfast cereals are available for consumption. Folic acid status in pregnant women is currently unknown. The aim of this first national study was to determine folate status in a representative sample of Belgian pregnant women and to assess the determinants of folate status in the first and third trimester of pregnancy. The latter is of interest in assessing the risk of NTD based on early pregnancy folate status and of assessing the risk of developing folate deficiency during pregnancy.
MATERIALS AND METHODS Sampling
The target population of the survey comprised all pregnant women in Belgium during the first and the third trimester of pregnancy in the period from September 2010 to June 2011.
The women were selected according to a multi-stage proportionateto-size stratified sampling design as recommended for studies assessing iodine deficiency. 16 Belgium was divided into two regions. In each region, the hospitals were ordered by province and size based on the number of deliveries during the past year, and 60 clusters of four hospitals were selected per region using systematic sampling while accounting for the number of deliveries to have enough replacement hospitals in case hospitals refused to participate. Out of these 60 clusters, 30 clusters were randomly selected, and within each cluster, the first hospital was invited to participate. In each hospital, all gynaecologists were invited to participate to level out a possible gynaecologist effect. The aim was to include 22 women per cluster of which 11 in the first trimester and 11 in the third trimester of pregnancy.
Data collection
This study was conducted according to the guidelines laid down in the Declaration of Helsinki, and all procedures involving human subjects were approved by the medical ethical committee of the Erasme Hospital in Brussels. The field work took place between September 2010 and June 2011.
Upon informed consent from the pregnant women, blood samples were collected and a general questionnaire about socio-demographic and socio-economic characteristics, trimester of pregnancy, smoking and alcohol drinking behaviour during pregnancy and during the previous 4 weeks, diseases and medication and use of food supplements was completed face-to-face with a study nurse. Body mass index was obtained from weight and height recorded by the gynaecologist during the first consultation for both women in the first and the third trimester of pregnancy.
Analysis of samples
Approximately 5 ml whole blood was collected by venipuncture into an EDTA tube. The samples arrived the same day of collection to the central laboratory and were kept at 5 1C until assay within 24 h. Vitamin C (2% solution) was added to 100 ml of total blood, mixed with a vortex and incubated for 70 min in the dark at room temperature. Erythrocyte (RBC) folate was measured by chemo luminescence using the Modular Analytic System (Elecsys, Roche, EE170 (CA 181), Mannheim, Germany). Samples were not diluted if they reached a folate concentration of 20 ng/ml corresponding to RBC folate concentration of 1000 ng/ml. Folate analysis was performed on whole blood and converted to RBC folate using the haematocrit value without correction for serum folate.
Statistical analyses
The statistical analyses were carried out using STATA 10.1 (StataCorp, College Station, TX, USA). As RBC folate concentration is not normally distributed, non-parametric methods were used. The median RBC folate was used as the measure of central tendency. Differences between regions, trimesters and age groups were explored using two-sample Wilcoxon ranksum test or Kruskal-Wallis equality-of-populations rank test. Associations between the RBC folate level and several predictor variables were estimated for both women in the first and third trimester of pregnancy separately through stepwise multiple linear regression after checking for linearity, normality and homogeneity of variance. The RBC folate level was root square transformed (first trimester women) and logarithmically transformed (third trimester women) before performing the regression analysis. The following predictor variables were included: age, region, ethnicity, body mass index, smoking behaviour, alcohol drinking behaviour, use of folic acid-containing food supplements, education level, number of pregnancies, planning of pregnancy and two interaction terms: education level*ethnicity and number of pregnancies*age.
RESULTS
Among the hospitals invited to participate in the survey, only one hospital refused and had to be replaced. Some hospitals were selected two (n ¼ 3) or three times (n ¼ 1) in the systematic sampling process because of the high number of women attending their antenatal clinics. In total, 55 hospitals instead of 60 were included in the survey. Among the 1311 pregnant women participating in the survey, there were 271 from Brussels, 597 from Flanders and 437 from Wallonia ( Figure 1 ; Table 1 ). The mean age of pregnant women was similar in the three regions. For one hospital (n ¼ 23 women), certain questions (mainly nationality, ethnicity and education level) needed to be omitted from the questionnaire upon decision of the ethical committee of this particular hospital.
The characteristics of the pregnant women included in the study are shown in Table 2 . The mean body mass index was 24.4 kg/m 2 , the same among first and third trimester pregnant women. In both samples of women, more than 50% of the women included had a lower education level, which means only completion of secondary school or even lower education. More or less 20% of the women in both samples were from non-Caucasian origin. Of women in the first trimester, 20% smoked during pregnancy, while 14% of women in the third trimester reported smoking during pregnancy. In addition, 11% of women in the first trimester and 12% of women in the third trimester reported having drunk alcohol during the previous 4 weeks ( Table 2) . Of all pregnant women included, 640 were in the first trimester of pregnancy, whereas 666 were in the third trimester and 2 were in the second trimester of pregnancy. For 40.8% of the women in the first trimester and 42.9% of the women in the third trimester, this was their first gestation (not known for 0.4% of the women), whereas for 45.2% of the women in the first trimester and 46.3% of the women in the third trimester (not known for 1.4% of the women), this would be their first child.
More or less 4% of the women had had a miscarriage at least once (4.7% of the women in the first and 3.9% of the women in the third trimester of pregnancy, respectively).
According to 78.9% of the women in the first trimester and 76.7% of the women in the third trimester, their pregnancy was planned and for 3.3% of the women this information was not available.
The median RBC folate concentration among Belgian pregnant women was 459 ng/ml (interquartile range ¼ 352-569 ng/ml). Only 0.15% of the women had a RBC folate level below 140 ng/ml, indicating depletion of folate stores, and 35% had a level below 400 ng/ml corresponding to folate insufficiency for the prevention of NTD. In addition, 14% of the women had a RBC folate concentration below 300 ng/ml, a level that has been associated with a higher risk of NTD compared with the level of (Table 3 ). The median RBC folate concentration among pregnant women in the first trimester was significantly lower than women in the third trimester of pregnancy; 436 ng/ml and 496 ng/ ml, respectively. RBC folate levels were significantly higher in Flanders than in Wallonia (Table 3 ). The differences in RBC folate level among the different age groups were also statistically significant (Po0.001); the level was highest in the oldest age group (431 years; 502 ng/ml) and lowest in the youngest age group (p26 years; 420 ng/ml).
Of all women included, 76.2% reported taking at least one food supplement during pregnancy. For 69.1% of women in the first trimester and 76.2% of women in the third trimester, the supplement contained folic acid. Only 41.2% of the women in the first trimester and 21.9% of the women in the third trimester started taking the supplement before pregnancy.
For both first and third trimester pregnant women, unplanned pregnancy and smoking during pregnancy were associated with a lower RBC folate concentration. In addition, a higher education level and the intake of folic acid containing multivitamins were associated with a higher RBC folate concentration in both samples of pregnant women when other factors remained constant (Table 4 ). For women in the first trimester of pregnancy, RBC folate concentrations were significantly lower in Brussels and Wallonia than in Flanders and North-African women had lower RBC folate concentrations compared with Caucasian women when other factors remained constant. In addition, nulliparity was associated with a higher RBC folate concentration but the interaction between age and parity revealed the opposite. For women in the third trimester of pregnancy, a younger age was associated with a lower RBC folate concentration and the interaction between age and parity revealed that nulliparity was associated with a higher RBC folate concentration (Table 4) .
DISCUSSION
Nearly, 35% of the pregnant women in Belgium had a RBC folate concentration below 400 ng/ml, which is generally recognised as the threshold for protecting the fetus for NTD, whereas 14% of the women had a RBC folate concentration below 300 ng/ml, a level associated with a higher risk of NTD compared with the level of 15-20  7  2  11  10  21  17  21-25  34  27  77  51  56  73  26-30  41  39  108  149  76  58  31-35  34  53  69  75  49  45  36-40  14  14  23  19  13  24  41-45  2  3  1  3  3  2  Total  132  138  289  307  218  219 Six missing data for age. a According to region of the hospital. 400 ng/ml. For women in the first trimester of pregnancy, those percentages were 39% and 15%, respectively. Folate deficiency, at a level below which there is depletion of folate stores, defined by RBC folate concentration below 140 ng/ml, was uncommon in Belgian pregnant women. Folate status was significantly higher among women in the third trimester of pregnancy compared with women in the first trimester of pregnancy and increased with education level. This is probably due to the fact that most women take supplements containing folic acid during pregnancy instead of starting before pregnancy, and that more educated women are better informed about the benefices of folic acid.
Also women who reported that their pregnancy was planned and women who did not smoke had higher RBC folate levels, both during first and third trimester of pregnancy. In first trimester, pregnant women folate status was higher in Flanders than in Wallonia.
Our findings corroborated a previous mono-centre study in Brussels (Belgium) reporting that the folic acid use among multiethnic pregnant women in Brussels was higher in educated or employed women. 17 This has been found also in a study from the UK. 18 In Hungary, it was found that factors influencing preconceptional folic acid consumption were planning of pregnancy, previous infertility therapy, multivitamin intake before pregnancy and folic acid intake during pregnancy. Probability of taking folic acid during pregnancy increased with age and decreased with gestational age. 19 In Norway, women who reported using folic acid supplementation from 1 month before pregnancy throughout the first trimester more frequently reported higher maternal and paternal education, planned pregnancies, infertility treatments or chronic diseases. They were also more likely to be older, married and non-smokers, and to have higher income and lower parity. 20 In Arkansas, a study among 322 women revealed that age, race, educational level, folic acid awareness, marital status, pregnancy intent and other preventive health behaviours were the most important predictors of taking folic acid supplements. 21 In the national birth defects prevention study in the US women who did not take periconceptional folic acid supplements tended to be non-white, have lower education levels, be younger than 25 years old, be nulliparous, smoke, have no previous miscarriage and no fertility treatments, begin prenatal care and become aware of their pregnancy after the first trimester, have non-planned pregnancies, and eat less breakfast cereals. 22 Also other studies found that women who did not follow the supplementation recommendations were often under 25 or under 19 years of age, of low socio-economic status or born in another country. [23] [24] [25] [26] However, it is important to note that in countries such as the US and the UK fewer than 50% of the pregnancies are planned, 27, 28 which contrasts with countries such as Norway where 80% of the pregnancies are planned. 20 In those countries, information can have a bigger impact. In addition, in the European countries mentioned above currently only voluntary fortification of specific foods with folic acid is permitted while in the US voluntary fortification is permitted alongside mandatory fortification. Mandatory fortification of flour in the UK has been In the UK and Norway, there is an official governmental recommendation that women planning a pregnancy should take 0.4 mg of folic acid supplementation before conception and throughout the first trimester of pregnancy. In Hungary in 1998, the National Board of Hungarian Gynaecologists recommended 0.4 mg/day folic acid throughout pregnancy to prevent NTD. They did not mention preconceptional folic acid. 29 The cutoff values for RBC folate deficiency, as for other micronutrients, should be interpreted taking into account the analytical methods for determining RBC folate, as there is lack of agreement between the different methods that may lead to an underestimation of inadequate folate status. 15, 30 In addition, erythrocyte folate concentration may underestimate the extent of folate depletion during pregnancy, when the depletion is rapid, because the concentration reflects folate stores at the time of red cell synthesis. Thus, during the progressive development of a deficiency state, erythrocyte folate will always lag behind more acute markers such as serum folate. 31 Moreover, several additional factors may affect RBC folate concentration, which were not taken into account in this study, such as vitamin B12 deficiency, haemorrhage or haemolytic anaemia and iron deficiency. In addition, certain drugs may affect the absorption of folate (for example, sulfasalazine, aspirine and perhaps cholestyramine), whereas others such as certain anticonvulsants interfere with the metabolism of folate. 31 A limitation of the present study was that a certified standard 'whole blood standard' was not used.
In Belgium, there has never been any policy on folic acid supplementation or fortification. According to the findings of this study, most pregnant women take multivitamins during pregnancy. However, despite the fact that 78% of pregnancies were planned, nearly 39% of women in the first trimester and 31% of women in the third trimester did not attain the RBC folate concentrations necessary to prevent NTD. In Belgium, the number of NTD per 10 000 births in one region of Flanders (Antwerp) was about 9.35 and in one region in Wallonia (Hainaut) about 8.93 per The routine gynaecologic visit and general practitioner visit are an ideal opportunity to counsel women of reproductive age to take folic acid daily before and during pregnancy.
In conclusion, 39% of the women in the first trimester have a folic status that might not be optimal to prevent NTD.
Although the percentage of women taking multivitamins is quite high in Belgium, less than one out of two women start taking those before pregnancy. In addition, some groups of women are at higher risk of inadequate folate status, which advocates for targeting specific population groups.
